Skip to main content
. 2020 Aug 29;11(21):6299–6318. doi: 10.7150/jca.47629

Table 5.

Multivariate Cox regression analysis

Exposure Non-adjusted Adjust I Adjust II Adjust III
Risk Score 6.11 (2.01, 18.59) 0.0014 7.66 (2.28, 25.70) 0.0010 7.66 (2.28, 25.70) 0.0010 7.50 (1.93, 29.18) 0.0037
Age 1.02 (0.99, 1.05) 0.1665 1.02 (0.99, 1.05) 0.2208 1.03 (1.00, 1.06) 0.0806 1.02 (0.99, 1.06) 0.1834
Sex
Male 1 1 1 NA
Female 1.26 (0.71, 2.24) 0.4278 1.22 (0.68, 2.17) 0.5065 1.23 (0.69, 2.19) 0.4921 NA
Size (cm) 1.22 (1.01, 1.47) 0.0422 1.26 (1.02, 1.55) 0.0318 1.24 (1.00, 1.53) 0.0450 1.23 (0.97, 1.57) 0.0828
KRAS mutation
Wildtype 1 1 1 NA
Mutant 1.21 (0.51, 2.86) 0.6593 1.19 (0.50, 2.84) 0.6990 0.95 (0.39, 2.27) 0.9016 NA
TP53 mutation
Wildtype 1 1 1 NA
Mutant 1.27 (0.68, 2.37) 0.4612 1.40 (0.73, 2.66) 0.3086 1.10 (0.55, 2.20) 0.7773 NA
CDKN2A mutation
Wildtype 1 1 1 1
Mutant 1.87 (1.04, 3.36) 0.0362 2.02 (1.07, 3.80) 0.0290 1.48 (0.75, 2.93) 0.2546 0.79 (0.37, 1.66) 0.5279
SMAD4 mutation
Wildtype 1 1 1 NA
Mutant 0.72 (0.37, 1.39) 0.3267 0.75 (0.39, 1.46) 0.4045 0.85 (0.43, 1.68) 0.6420 NA
BRCA1 mutation
Wildtype 1 1 1 1
Mutant 4.06 (1.43, 11.53) 0.0086 3.72 (1.26, 10.97) 0.0171 2.68 (0.89, 8.07) 0.0807 2.31 (0.61, 8.72) 0.2188
BRCA2 mutation
Wildtype 1 1 1 NA
Mutant 1.87 (0.45, 7.80) 0.3892 1.94 (0.44, 8.65) 0.3829 2.04 (0.46, 9.10) 0.3476 NA
Site
Head of Pancreas 1 1 1 1
Body and tail of Pancreas and others 0.39 (0.14, 1.10) 0.0744 0.42 (0.15, 1.19) 0.1019 0.41 (0.14, 1.20) 0.1052 0.54 (0.15, 1.95) 0.3459
Subtype
Pancreas-Adenocarcinoma Ductal Type 1 1 1 NA
Pancreas-Adenocarcinoma-Other Subtype 0.60 (0.22, 1.68) 0.3336 0.67 (0.24, 1.89) 0.4447 0.76 (0.27, 2.20) 0.6180 NA
Grade
G1 and G2 1 1 1 1
G3 and G4 1.41 (0.79, 2.53) 0.2487 1.33 (0.73, 2.41) 0.3471 1.10 (0.60, 2.01) 0.7582 1.12 (0.55, 2.28) 0.7447
T
T1 and T2 1 1 1 1
T3 and T4 2.45 (0.87, 6.88) 0.0887 inf. (0.00, Inf) 0.9958 inf. (0.00, Inf) 0.9960 1.75 (0.47, 6.47) 0.4049
N
N0 1 1 1 1
N1 2.33 (1.12, 4.85) 0.0231 2.48 (0.96, 6.45) 0.0620 2.26 (0.87, 5.86) 0.0926 1.61 (0.63, 4.09) 0.3195
AJCC stage
I 1 1 1 NA
II and III 1.63 (0.58, 4.57) 0.3547 1.53 (0.54, 4.32) 0.4194 1.43 (0.51, 4.02) 0.4991 NA
Residual tumor
R0 1 1 1 1
R1 2.14 (1.17, 3.92) 0.0132 2.27 (1.21, 4.26) 0.0108 2.00 (1.06, 3.78) 0.0331 1.25 (0.55, 2.83) 0.5878
R2 1.92 (0.25, 14.58) 0.5270 1.92 (0.24, 15.22) 0.5387 2.61 (0.32, 21.37) 0.3718 4.69 (0.45, 48.71) 0.1958
Surgical treatment
Whipple 1 1 1 NA
Distal Pancreatectomy 0.55 (0.20, 1.54) 0.2520 0.60 (0.21, 1.69) 0.3308 0.60 (0.21, 1.72) 0.3419 NA
Others 0.00 (0.00, Inf) 0.9971 0.00 (0.00, Inf) 0.9971 0.00 (0.00, Inf) 0.9972 NA
History of radiation therapy
No 1 1 1 1
Yes 0.28 (0.12, 0.66) 0.0035 0.27 (0.11, 0.65) 0.0034 0.27 (0.11, 0.66) 0.0042 0.43 (0.16, 1.19) 0.1059
History of targeted molecular therapy
No 1 1 1 1
Yes 0.18 (0.10, 0.33) < 0.0001 0.16 (0.08, 0.30) < 0.0001 0.14 (0.07, 0.28) < 0.0001 0.24 (0.07, 0.84) 0.0260
History of chemotherapy
No 1 1 1 1
Yes 0.36 (0.20, 0.66) 0.0008 0.26 (0.14, 0.49) < 0.0001 0.22 (0.11, 0.43) < 0.0001 0.48 (0.13, 1.79) 0.2740
Tobacco smoking history
Lifelong non-smoker 1 1 1 NA
Current or former smoker 0.80 (0.44, 1.44) 0.4526 0.81 (0.45, 1.47) 0.4970 0.93 (0.51, 1.70) 0.8087 NA
Alcohol drinking history
No 1 1 1 NA
Yes 1.45 (0.74, 2.86) 0.2782 1.35 (0.66, 2.76) 0.4175 1.08 (0.51, 2.25) 0.8467 NA
History of chronic pancreatitis
No 1 1 1 NA
Yes 0.70 (0.30, 1.66) 0.4209 0.77 (0.31, 1.89) 0.5656 0.49 (0.20, 1.24) 0.1319 NA
History of diabetes
No 1 1 1 1
Yes 0.51 (0.24, 1.10) 0.0849 0.54 (0.24, 1.19) 0.1264 0.62 (0.28, 1.38) 0.2417 0.32 (0.13, 0.79) 0.0141
History of prior malignancy
No 1 1 1 NA
Yes 1.59 (0.56, 4.52) 0.3848 1.38 (0.48, 4.02) 0.5503 1.03 (0.35, 3.02) 0.9599 NA

Adjust I model adjust for: Age, Sex, and AJCC Stage;

Adjust II model adjust for: Age, Sex, AJCC Stage, and Risk Score;

Adjust III model adjust for parameters with p < 0.25 based on univariate analysis.